JP2007505601A5 - - Google Patents

Download PDF

Info

Publication number
JP2007505601A5
JP2007505601A5 JP2006525796A JP2006525796A JP2007505601A5 JP 2007505601 A5 JP2007505601 A5 JP 2007505601A5 JP 2006525796 A JP2006525796 A JP 2006525796A JP 2006525796 A JP2006525796 A JP 2006525796A JP 2007505601 A5 JP2007505601 A5 JP 2007505601A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
protein
muc
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006525796A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007505601A (ja
Filing date
Publication date
Priority claimed from GBGB0321614.0A external-priority patent/GB0321614D0/en
Application filed filed Critical
Publication of JP2007505601A publication Critical patent/JP2007505601A/ja
Publication of JP2007505601A5 publication Critical patent/JP2007505601A5/ja
Pending legal-status Critical Current

Links

JP2006525796A 2003-09-15 2004-09-13 ワクチン Pending JP2007505601A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0321614.0A GB0321614D0 (en) 2003-09-15 2003-09-15 Vaccines
PCT/EP2004/010323 WO2005025612A1 (en) 2003-09-15 2004-09-13 Vaccines

Publications (2)

Publication Number Publication Date
JP2007505601A JP2007505601A (ja) 2007-03-15
JP2007505601A5 true JP2007505601A5 (enExample) 2007-06-14

Family

ID=29227138

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006525796A Pending JP2007505601A (ja) 2003-09-15 2004-09-13 ワクチン

Country Status (6)

Country Link
US (1) US20070042047A1 (enExample)
EP (1) EP1663301A1 (enExample)
JP (1) JP2007505601A (enExample)
CA (1) CA2537489A1 (enExample)
GB (1) GB0321614D0 (enExample)
WO (1) WO2005025612A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0304634D0 (en) * 2003-02-28 2003-04-02 Glaxo Group Ltd Vaccines
WO2007038083A2 (en) * 2005-09-21 2007-04-05 New York University Heat shock proteins from mycobacterium leprae and uses thereof
JP2009544291A (ja) * 2006-07-25 2009-12-17 フォージー ヴァクシンズ ピーティーワイ エルーティーディー ムチン1(muc1)t細胞エピトープ由来ペプチド含有癌ワクチン
WO2008035350A1 (en) * 2006-09-21 2008-03-27 Vaxil Biotherapeutics Ltd. Antigen specific multi epitope vaccines
WO2021046364A1 (en) * 2019-09-06 2021-03-11 Bio Capital Holdings, LLC Genelight cultures and extracts and applications thereof
CN113480666B (zh) * 2021-08-13 2024-01-26 郑州伊美诺生物技术有限公司 Ca153融合蛋白及其制备方法和ca153检测质控品或校准品

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2171454T3 (es) * 1993-06-04 2002-09-16 Whitehead Biomedical Inst Proteinas de estres y sus usos.
DE69836206T2 (de) * 1997-02-07 2007-08-23 Merck & Co., Inc. Synthetische hiv gag gene
WO2001018035A2 (en) * 1999-09-08 2001-03-15 Transgene S.A. Muc-1 derived peptides
CN1411512A (zh) * 1999-10-20 2003-04-16 约翰霍普金斯大学医学院 嵌合的免疫原性组合物及其编码核酸
WO2001057068A1 (en) * 2000-02-01 2001-08-09 The Austin Research Institute Mucin-1 derived antigens and their use in immunotherapy
US20050031649A1 (en) * 2003-08-06 2005-02-10 Yongli Yu Recombinant fusion proteins comprising BCG heat shock protein 65 and the epitope of MUC1

Similar Documents

Publication Publication Date Title
ES2925098T3 (es) Activador triple que activa el receptor de glucagón, GLP-1 Y GIP
JP2015501840A5 (enExample)
JP2009544333A5 (enExample)
JP2014500724A5 (enExample)
CA2158455A1 (en) Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide and their uses in vaccines and disease treatments
JP2008508859A5 (enExample)
JP2006149406A5 (enExample)
JP2017513502A5 (enExample)
JP2013507907A5 (enExample)
JP2006187292A5 (enExample)
FI3642340T3 (fi) Muunneltu l-asparaginaasi
JP2020023567A5 (enExample)
RU2009117325A (ru) Слитый белок теломеразной обратной транскриптазы, кодирующие его нуклеотиды и их применение
JP2015509707A5 (enExample)
JP2009112314A5 (enExample)
JP2020510426A5 (enExample)
JP2020536489A5 (enExample)
JP2003530088A5 (enExample)
JP2025094154A5 (enExample)
JP2005526520A5 (enExample)
JP2019508403A5 (enExample)
JP2019534884A5 (enExample)
JP2019505567A5 (enExample)
JP2007505601A5 (enExample)
JP2005512518A5 (enExample)